ArticleInternational journal of clinical pediatric dentistry2025
Nonsurgical Management of Drug-induced Gingival Enlargement in a Young Adolescent with Chronic Kidney Disease: A Case Report.
Article in International journal of clinical pediatric dentistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug-induced gingival enlargement represents a well-documented adverse effect of medications utilized in treating systemic conditions. This case reports a 13-year-old female with chronic kidney disease and hypertension who was under the medication of atenolol and amlodipine for 5 years. Despite well-controlled blood pressure, the child developed a gingival enlargement, which is a documented side effect of amlodipine. The management included counseling, oral hygiene maintenance, full-arch scaling, and transition to alternate antihypertensive clonidine; the patient was reverted back to amlodipine after 1 month due to inadequate blood pressure control with clonidine. The patient exhibited no recurrence of gingival enlargement at the 3-year follow-up. This case highlights the importance of interdisciplinary management of drug-induced gingival enlargement and good oral hygiene measures to prevent gingival enlargement in calcium channel blocker intake. Clinical significance: Children who require medication of calcium channel blockers should be consulted with a pediatric dentist prior to commencement of drugs for instructions regarding importance of oral hygiene technique and scaling. Poor oral hygiene causes inflammation, which further acts as a risk factor for gingival growth. How to cite this article: Tamchos R, Rathod P, Kapur A,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.